Home » Europe Oral Solid Dosage Contract Manufacturing Market

Europe Oral Solid Dosage Contract Manufacturing Market By Type Outlook (Tablets, Capsules, Powders, Granules) By Mechanism Outlook (Immediate-release, Delayed-release, Controlled-release) By End-user (Large Size Companies, Medium & Small Size Companies); By Therapeutic Area (Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Oncology, Others) – Growth, Future Prospects & Competitive Analysis, 2018 – 2032

Price: $2999

Published: | Report ID: 32265 | Report Format : PDF

Europe Oral Solid Dosage Contract Manufacturing Market Overview

The European market for oral solid dosage contract manufacturing is currently undergoing significant expansion and is projected to continue this trajectory. In 2023, the market was valued at USD 6,280.24 million, with an anticipated compound annual growth rate (CAGR) of about 5.5% from 2023 to 2032. By 2032, this growth led to a market valuation of USD 10,441.43 million, showcasing significant expansion over the decade. This growth is largely fueled by the increasing demand for oral solid dosage pharmaceuticals, such as tablets, capsules, powders, and granules. Key drivers include the complexity of emerging drug compounds, advancements in drug delivery technologies, and the need for enhanced bioavailability and patient compliance.

Contract Development and Manufacturing Organizations (CDMOs) are making substantial investments in the development of oral solid dosage forms, further propelling market growth. Prominent market participants comprise Catalent Inc., Lonza Group, Piramal Pharma Solutions, Aenova, Jubilant, Boehringer Ingelheim, AbbVie Contract Manufacturing, Patheon, Recipharm, Next Pharma AB, Siegfried AG, and Corden Pharma. The market dynamics are also shaped by regulatory approval processes and an expanding customer base for contract manufacturers.

There is a growing demand for products such as high-potency compounds, fixed-dose combinations, orally disintegrating tablets, and flavored chewables, which is contributing to the market’s expansion. The European market is expected to grow at a CAGR of 5.5% over the next decade, with Germany leading in sales of oral solid dosage pharmaceuticals within the region.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Drivers

The European Oral Solid Dosage Contract Manufacturing Market is significantly influenced by the increasing demand for generic medications and advancements in drug development technologies. As patents for numerous blockbuster drugs expire, there is a heightened need for cost-effective generic drugs, boosting the demand for contract manufacturing organizations (CMOs) skilled in oral solid dosage forms. Technological advancements further propel this market with innovations in drug formulation and manufacturing processes, such as modified-release technologies and the handling of highly potent active pharmaceutical ingredients (APIs). Additionally, the stringent regulatory environment in Europe mandates high standards in pharmaceutical manufacturing, compelling companies to outsource to CMOs that specialize in meeting these rigorous standards.

Demographic and industry trends also play a crucial role in shaping the market. Europe’s aging population and the rise in chronic diseases spur a higher demand for medications, including oral solid dosages. This is complemented by the pharmaceutical industry’s shift towards cost-effectiveness and production efficiency, leading to increased outsourcing to contract manufacturers. Furthermore, there’s a growing focus on specialized therapeutic areas like oncology and neurology, where oral solid dosages are often preferred. The globalization of pharmaceutical supply chains, increased R&D investment, and the trend towards outsourcing complex formulations contribute significantly to market growth. Strategic collaborations between pharmaceutical companies and CMOs are becoming more prevalent, offering advantages in cost, quality, and speed to market, thus fortifying the European Oral Solid Dosage Contract Manufacturing Market.

Market Restraints

The European Oral Solid Dosage Contract Manufacturing Market faces several restraints, including high operational costs due to the need to comply with strict European regulatory standards, which also pose complex and time-consuming compliance challenges. Intense competition within the market pressures profitability and necessitates continual investment in new technologies to keep pace with advancements in drug formulation and manufacturing. Additionally, the market is susceptible to global supply chain disruptions, which can affect the procurement of raw materials and the distribution of products. The dependency on the drug development pipeline of client pharmaceutical companies adds a layer of uncertainty, with any slowdown or failure impacting demand for manufacturing services. Moreover, issues with capacity utilization can lead to increased costs or compromised quality, while stringent environmental and safety regulations further complicate operations and add to the costs, collectively posing significant challenges to the growth and efficiency of the market. Top of Form

Opportunities

The European Oral Solid Dosage Contract Manufacturing Market presents several opportunities that can drive growth and expansion:

  1. With the global pharmaceutical market growing, especially in emerging economies, there are opportunities for European contract manufacturers to expand their operations and client base into these new markets. This expansion can lead to increased revenue streams and a more diversified client portfolio.
  2. As drug formulations become more complex, there is a growing demand for advanced manufacturing technologies. Investing in these technologies can help contract manufacturers offer more sophisticated services, such as controlled-release formulations and the handling of potent APIs, thus attracting more business.
  3. Forming strategic partnerships with pharmaceutical companies, especially for long-term contracts, can provide stability and steady revenue streams. Collaborations in areas like R&D can also lead to innovative solutions and a stronger market position.
  4. Specializing in niche therapeutic areas, such as orphan drugs or personalized medicine, presents an opportunity for contract manufacturers to differentiate themselves and command higher prices for their specialized services.
  5. With increasing awareness of environmental issues, adopting sustainable and eco-friendly manufacturing practices can not only reduce operational costs in the long run but also appeal to clients who are increasingly valuing sustainability.
  6. Implementing digital technologies and automation in manufacturing processes can improve efficiency, reduce errors, and lower costs. This could include adopting Industry 4.0 technologies, data analytics, and AI-driven predictive maintenance.
  7. Offering regulatory expertise as a service can be a significant advantage. Helping clients navigate the complex regulatory landscape in Europe can be a valuable addition to our core manufacturing services.
  8. Expanding manufacturing capacity or offering flexible production capabilities can meet the varying demands of clients, from small-scale pilot batches to large-scale commercial production.
  9. Maintaining high standards of quality and compliance can be a key differentiator in the market. This not only ensures customer satisfaction but also minimizes the risk of regulatory issues.
  10. Providing customized solutions tailored to the specific needs of each client can enhance client relationships and lead to repeat business and referrals.

Interesting Facts about the European Oral Solid Dosage Contract Manufacturing Market

  • Estimated at $6,280.24 million in 2023, the European oral solid dosage contract manufacturing market is projected to grow at a CAGR of about 5.5% from 2023 to 2032.
  • The market is experiencing a decline in its customer base, prompting manufacturers to enhance their offerings and adapt to the diverse expectations of sponsor companies.
  • The Asia Pacific region, particularly China and India, is significantly contributing to the growth of the industry, indicating a shift in global market dynamics.
  • Opportunities for growth are seen in high-potency products, including fixed-dose combinations, orally disintegrating tablets, minitablets, flavored chewables, and multi-layered tablets.
  • Stringent regulatory approval processes are a major market restraint, but businesses are using advanced technologies to increase dosage form bioavailability, presenting new industry opportunities.
  • The global oral solid dosage contract manufacturing market is expected to grow at a CAGR of 6.40% between 2023 and 2032, reaching a value of USD 48,167.19 million by 2032.
  • Dominant market players include Catalent Inc., Lonza Group, Piramal Pharma Solutions, Aenova, Jubilant, Boehringer Ingelheim, AbbVie Contract Manufacturing, Patheon, Recipharm, and Siegfried AG.

Competitive Landscape

The competitive landscape of the European Oral Solid Dosage Contract Manufacturing market is characterized by the presence of several key players, each employing various strategies to strengthen their market position. These strategies include product innovation, mergers and acquisitions, expansion into new markets, and enhancing production capabilities. Some of the notable players in the European Oral Solid Dosage Contract Manufacturing market are:

  • Catalent, Inc.
  • Lonza
  • AbbVie Inc.
  • Aenova Group
  • Adare Pharma Solutions
  • Boehringer-Ingelheim International GmbH
  • Jubilant Pharmova Limited
  • Thermo Fisher Scientific
  • Recipharm AB
  • Corden Pharma International
  • Siegfried Holding AG
  • Piramal Enterprises Ltd.
  • Saffron Medicare Pvt. Ltd.
  • Aurobindo Pharma Ltd.
  • Reddy’s Laboratories Ltd.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Regional Analysis

The European Oral Solid Dosage Contract Manufacturing Market exhibits a multifaceted and dynamic regional landscape, each contributing distinctively to the industry’s overall framework. In Western Europe, markets such as Germany, France, and the UK are pivotal. Germany’s prominence is underpinned by its exceptional manufacturing capabilities and rigorous adherence to quality standards, positioning it as a central player in the sector. France leverages its robust healthcare infrastructure and a strong emphasis on research and development to spearhead innovation in drug formulations. The UK, notwithstanding the regulatory complexities post-Brexit, maintains its significance in the market, buoyed by an established pharmaceutical industry and a steadfast commitment to research and development.

In contrast, Central and Eastern Europe, with nations like Poland and Hungary, are gaining traction as increasingly attractive destinations for contract manufacturing, offering competitive production costs and evolving quality standards. Their strategic location as gateways to the broader EU market confers additional logistical advantages. Southern Europe, particularly Italy and Spain, is recognized for its longstanding pharmaceutical industries, characterized by a blend of cost-efficiency and strategic positioning for exports. The Nordic countries, including Sweden and Denmark, though smaller in market size, distinguish themselves through a high index of innovation, advanced technological prowess, and an unwavering focus on quality and sustainability. These attributes render them integral to the industry. Lastly, the Benelux region, comprising Belgium, the Netherlands, and Luxembourg, plays a crucial role in the market’s logistics network. As principal transit hubs, these countries facilitate effective pharmaceutical distribution across Europe, further bolstered by a dense concentration of pharmaceutical entities and contract manufacturing organizations. Collectively, these regional dynamics forge a diverse and robust European oral solid dosage contract manufacturing market.

Segmentation

By Type Segment

  • Tablets
  • Capsules
  • Powders
  • Granules
  • Others

By Mechanism Segment

  • Immediate Release
  • Delayed Release
  • Controlled Release

By end-user segment

  • Large Companies
  • SMEs

By Therapeutic Area Segment

  • Cardiovascular
  • CNS
  • Gastrointestinal
  • Oncology
  • Others

Table of Content

Chapter No. 1 :………. Introduction.. 40

1.1.      Report Description. 40

1.1.1.    Purpose of the Report 40

1.1.2.    USP & Key Offerings. 40

1.2.      Key Benefits for Stakeholders. 40

1.3.      Target Audience. 41

1.4.      Report Scope  42

Chapter No. 2 :………. Executive Summary. 44

2.1.      OSD Contract Manufacturing Market Snapshot. 44

2.2.      Europe OSD Contract Manufacturing Market, 2018 – 2032 (USD Million) 45

Chapter No. 3 :………. Geopolitical Crisis Impact Analysis. 46

3.1.      Russia-Ukraine and Israel-Palestine War Impacts. 46

3.1.1.    Geopolitical Instability. 46

3.1.2.    Supply chain disruptions. 46

3.1.3.    Regulatory Challenges. 46

3.1.4.    Economic Impact 46

3.1.5.    Europe Market Dynamics. 46

Chapter No. 4 :………. OSD Contract Manufacturing Market – Industry Analysis. 47

4.1.      Introduction  47

4.2.      Market Drivers  48

4.2.1.    Complexity of New Molecules. 48

4.2.2.    Advances in Drug Delivery. 48

4.2.3.    Growing Demand for Oral Solid Dosages. 48

4.2.4.    Expansion of Manufacturing Units. 49

4.2.5.    Patent Expiry and Increasing Demand For Generic Drugs  49

4.3.      Market Restraints. 50

4.3.1.    Stringent Government Regulations. 50

4.3.2.    High Competition among CDMOs. 50

4.3.3.    Cultural Gaps and Time Zones. 50

4.4.      Market Opportunities. 51

4.4.1.    Technological Advancements. 51

4.4.2.    Particle Engineering. 51

4.4.3.    Mergers and Collaborations with Pharma and Biotech Firms. 51

4.4.4.    Flexible Business Models. 51

4.5.      Porter’s Five Forces Analysis. 52

4.6.      Value Chain Analysis. 54

Chapter No. 5 :………. Competitive Landscape Analysis. 55

5.1.      Company Market Share Analysis – 2023. 55

5.1.1.    Europe OSD Contract Manufacturing Market: Company Market Share, by Revenue, 2023. 55

5.1.2.    Europe OSD Contract Manufacturing Market: Top 6 Company Market Share, by Revenue, 2023. 56

5.1.3.    Europe OSD Contract Manufacturing Market: Top 3 Company Market Share, by Revenue, 2023. 57

5.1.      Europe OSD Contract Manufacturing Market Company Revenue Market Share, 2023. 58

5.2.      Company Assessment Metrics, 2023. 59

5.2.1.    Stars  59

5.2.2.    Emerging Leaders. 59

5.2.3.    Pervasive Players. 59

5.2.4.    Participants. 60

5.3.      Strategic Developments. 60

5.3.1.    Acquisitions & Mergers. 60

5.3.2.    Agreements & Collaborations. 62

5.3.3.    Expansion. 63

5.4.      Key Players Product Matrix. 64

Chapter No. 6 :………. PESTEL & Adjacent Market Analysis. 68

6.1.      PESTEL  68

6.1.1.    Political Factors. 68

6.1.2.    Economic Factors. 68

6.1.3.    Social Factors. 68

6.1.4.    Technological Factors. 68

6.1.5.    Environmental Factors. 69

6.1.6.    Legal Factors. 69

6.2.      Adjacent Market Analysis. 70

Chapter No. 7 :………. OSD Contract Manufacturing Market – By Type Segment Analysis. 72

7.1.      OSD Contract Manufacturing Market Overview, by Type Segment. 72

7.1.1.    Key Types. 72

7.1.2.    OSD Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032. 73

7.1.3.    OSD Contract Manufacturing Market Attractiveness Analysis, By Type. 74

7.1.4.    Incremental Revenue Growth Opportunity, by Type, 2024 – 2032. 75

7.1.5.    OSD Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032. 76

7.2.      Tablets  77

7.3.      Capsules  78

7.4.      Powders  79

7.5.      Granules  80

7.6.      Others  81

Chapter No. 8 :………. OSD Contract Manufacturing Market – By Mechanism Segment Analysis. 82

8.1.      OSD Contract Manufacturing Market Overview, by Mechanism Segment  82

8.1.1.    Key Mechanism Segments. 82

8.1.2.    OSD Contract Manufacturing Market Revenue Share, By Mechanism, 2023 & 2032. 83

8.1.3.    OSD Contract Manufacturing Market Attractiveness Analysis, By Mechanism.. 84

8.1.4.    Incremental Revenue Growth Opportunity, by Mechanism, 2024 – 2032. 85

8.1.5.    OSD Contract Manufacturing Market Revenue, By Mechanism, 2018, 2023, 2027 & 2032. 86

8.2.      Immediate Release. 87

8.3.      Delayed Release. 88

8.4.      Controlled Release. 89

Chapter No. 9 :………. OSD Contract Manufacturing Market – By End-user Segment Analysis. 90

9.1.      OSD Contract Manufacturing Market Overview, by End-user Segment  90

9.1.1.    Key End-user Segments. 90

9.1.2.    OSD Contract Manufacturing Market Revenue Share, By End-user, 2023 & 2032. 91

9.1.3.    OSD Contract Manufacturing Market Attractiveness Analysis, By End-user. 92

9.1.4.    Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032. 93

9.1.5.    OSD Contract Manufacturing Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 94

9.2.      Large Companies. 95

9.3.      SMEs  96

Chapter No. 10 :…….. OSD Contract Manufacturing Market – By Therapeutic Area Segment Analysis. 97

10.1.    OSD Contract Manufacturing Market Overview, by Therapeutic Area Segment  97

10.1.1.  Key Therapeutic Area Segments. 97

10.1.2.  OSD Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032. 98

10.1.3.  OSD Contract Manufacturing Market Attractiveness Analysis, By Therapeutic Area. 99

10.1.4.  Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032. 100

10.1.5.  OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 101

10.2.    Cardiovascular  102

10.3.    CNS  103

10.4.    Gastrointestinal 104

10.5.    Oncology  105

10.6.    Others  106

Chapter No. 11 :…….. OSD Contract Manufacturing Market – Europe. 107

11.1.    Europe  107

11.2.    Key Highlights  108

11.2.1.  Europe OSD Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 109

11.2.2.  Europe OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 111

11.2.3.  Europe OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 112

11.2.4.  Europe OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 113

11.2.5.  Europe OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 114

11.2.6.  Germany. 115

11.2.6.1.      Germany OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 115

11.2.6.2.      Germany OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 116

11.2.6.3.      Germany OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 117

11.2.6.4.      Germany OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 118

11.2.7.  UK  119

11.2.7.1.      UK OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 119

11.2.7.2.      UK OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 120

11.2.7.3.      UK OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 121

11.2.7.4.      UK OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 122

11.2.8.  France  123

11.2.8.1.      France OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 123

11.2.8.2.      France OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 124

11.2.8.3.      France OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 125

11.2.8.4.      France OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 126

11.2.9.  Italy  127

11.2.9.1.      Italy OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 127

11.2.9.2.      Italy OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 128

11.2.9.3.      Italy OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 129

11.2.9.4.      Italy OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 130

11.2.10.            Spain. 131

11.2.10.1.    Spain OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 131

11.2.10.2.    Spain OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 132

11.2.10.3.    Spain OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 133

11.2.10.4.    Spain OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 134

11.2.11.            Russia. 135

11.2.11.1.    Russia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 135

11.2.11.2.    Russia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 136

11.2.11.3.    Russia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 137

11.2.11.4.    Russia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 138

11.2.12.            BENELUX. 139

11.2.12.1.    BENELUX OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 139

11.2.12.2.    BENELUX OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 140

11.2.12.3.    BENELUX OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 141

11.2.12.4.    BENELUX OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 142

11.2.13.            Austria. 143

11.2.13.1.    Austria OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 143

11.2.13.2.    Austria OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 144

11.2.13.3.    Austria OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 145

11.2.13.4.    Austria OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 146

11.2.14.            Denmark. 147

11.2.14.1.    Denmark OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 147

11.2.14.2.    Denmark OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 148

11.2.14.3.    Denmark OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 149

11.2.14.4.    Denmark OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 150

11.2.15.            Sweden. 151

11.2.15.1.    Sweden OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 151

11.2.15.2.    Sweden OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 152

11.2.15.3.    Sweden OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 153

11.2.15.4.    Sweden OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 154

11.2.16.            Switzerland. 155

11.2.16.1.    Switzerland OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 155

11.2.16.2.    Switzerland OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 156

11.2.16.3.    Switzerland OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 157

11.2.16.4.    Switzerland OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 158

11.2.17.            Rest of Europe. 159

11.2.17.1.    Rest of Europe OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 159

11.2.17.2.    Rest of Europe OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 160

11.2.17.3.    Rest of Europe OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 161

11.2.17.4.    Rest of Europe OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 162

Chapter No. 12 :…….. Company Profiles. 163

12.1.    Catalent, Inc. 163

12.1.1.  Company Overview.. 163

12.1.2.  Product Portfolio. 164

12.1.3.  Financial Overview.. 164

12.2.    Lonza  165

12.2.1.  Company Overview.. 165

12.2.2.  Product Portfolio. 166

12.2.3.  Financial Overview.. 166

12.3.    AbbVie Inc. 167

12.3.1.  Company Overview.. 167

12.3.2.  Product Portfolio. 168

12.3.3.  Financial Overview.. 168

12.4.    Aenova Group  169

12.4.1.  Company Overview.. 169

12.4.2.  Product Portfolio. 170

12.4.3.  Financial Overview.. 170

12.5.    Adare Pharma Solutions. 171

12.5.1.  Company Overview.. 171

12.5.2.  Product Portfolio. 172

12.5.3.  Financial Overview.. 172

12.6.    Boehringer Ingelheim International GmbH.. 173

12.6.1.  Company Overview.. 173

12.6.2.  Product Portfolio. 174

12.6.3.  Financial Overview.. 174

12.7.    Jubilant Pharmova Limited. 175

12.7.1.  Company Overview.. 175

12.7.2.  Product Portfolio. 175

12.7.3.  Financial Overview.. 176

12.8.    Thermo Fisher Scientific. 177

12.8.1.  Company Overview.. 177

12.8.2.  Product Portfolio. 177

12.8.3.  Financial Overview.. 178

12.9.    Recipharm AB  179

12.9.1.  Company Overview.. 179

12.9.2.  Product Portfolio. 180

12.9.2.1.      Financial Overview.. 180

12.10. Corden Pharma International 181

12.10.1.            Company Overview.. 181

12.10.2.            Product Portfolio. 182

12.10.3.            Financial Overview.. 182

12.11. Siegfried Holding AG.. 183

12.11.1.            Company Overview.. 183

12.11.2.            Product Portfolio. 184

12.11.3.            Financial Overview.. 184

12.12. Piramal Enterprises Ltd. 185

12.12.1.            Company Overview.. 185

12.12.2.            Product Portfolio. 186

12.12.3.            Financial Overview.. 186

12.13. Saffron Medicare PVT. LTD.. 187

12.13.1.            Company Overview.. 187

12.13.2.            Product Portfolio. 188

12.13.3.            Financial Overview.. 188

12.14. Aurobindo Pharma Ltd. 189

12.14.1.            Company Overview.. 189

12.14.2.            Product Portfolio. 190

12.14.3.            Financial Overview.. 190

12.15. Dr. Reddy’s Laboratories Ltd. 191

12.15.1.            Company Overview.. 191

12.15.2.            Product Portfolio. 192

12.15.3.            Financial Overview.. 192

Chapter No. 13 :…….. Research Methodology. 193

13.1.    Research Methodology. 193

13.2.    Phase I – Secondary Research. 194

13.3.    Phase II – Data Modeling. 194

13.3.1.  Company Share Analysis Model 195

13.3.2.  Revenue Based Modeling. 195

13.4.    Phase III – Primary Research. 196

13.5.    Research Limitations. 197

13.5.1.  Assumptions. 197

 

List of Figures

FIG NO. 1……….. Europe OSD Contract Manufacturing Market Revenue, 2018 – 2032 (USD Million) 45

FIG NO. 2……….. Porter’s Five Forces Analysis for Europe OSD Contract Manufacturing Market 52

FIG NO. 3……….. Value Chain Analysis for Europe OSD Contract Manufacturing Market 54

FIG NO. 4……….. Company Share Analysis, 2023. 55

FIG NO. 5……….. Company Share Analysis, 2023. 56

FIG NO. 6……….. Company Share Analysis, 2023. 57

FIG NO. 7……….. OSD Contract Manufacturing Market – Company Revenue Market Share, 2023. 58

FIG NO. 8……….. Company Assessment Metrics. 59

FIG NO. 9……….. OSD Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032. 73

FIG NO. 10……… Market Attractiveness Analysis, By Type. 74

FIG NO. 11……… Incremental Revenue Growth Opportunity by Type, 2024 – 2032. 75

FIG NO. 12……… OSD Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032. 76

FIG NO. 13……… Europe OSD Contract Manufacturing Market for Tablets, Revenue (USD Million) 2018 – 2032. 77

FIG NO. 14……… Europe OSD Contract Manufacturing Market for Capsules, Revenue (USD Million) 2018 – 2032. 78

FIG NO. 15……… Europe OSD Contract Manufacturing Market for Powders, Revenue (USD Million) 2018 – 2032. 79

FIG NO. 16……… Europe OSD Contract Manufacturing Market for Granules, Revenue (USD Million) 2018 – 2032. 80

FIG NO. 17……… Europe OSD Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032. 81

FIG NO. 18……… OSD Contract Manufacturing Market Revenue Share, By Mechanism, 2023 & 2032. 83

FIG NO. 19……… Market Attractiveness Analysis, By Mechanism.. 84

FIG NO. 20……… Incremental Revenue Growth Opportunity by Mechanism, 2024 – 2032. 85

FIG NO. 21……… OSD Contract Manufacturing Market Revenue, By Mechanism, 2018, 2023, 2027 & 2032. 86

FIG NO. 22……… Europe OSD Contract Manufacturing Market for Immediate Release, Revenue (USD Million) 2018 – 2032. 87

FIG NO. 23……… Europe OSD Contract Manufacturing Market for Delayed Release, Revenue (USD Million) 2018 – 2032. 88

FIG NO. 24……… Europe OSD Contract Manufacturing Market for Controlled Release, Revenue (USD Million) 2018 – 2032. 89

FIG NO. 25……… OSD Contract Manufacturing Market Revenue Share, By End-user, 2023 & 2032. 91

FIG NO. 26……… Market Attractiveness Analysis, By End-user 92

FIG NO. 27……… Incremental Revenue Growth Opportunity by End-user, 2024 – 2032. 93

FIG NO. 28……… OSD Contract Manufacturing Market Revenue, By End-user, 2018, 2023, 2027 & 2032. 94

FIG NO. 29……… Europe OSD Contract Manufacturing Market for Large Companies, Revenue (USD Million) 2018 – 2032. 95

FIG NO. 30……… Europe OSD Contract Manufacturing Market for SMEs, Revenue (USD Million) 2018 – 2032. 96

FIG NO. 31……… OSD Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032. 98

FIG NO. 32……… Market Attractiveness Analysis, By Therapeutic Area. 99

FIG NO. 33……… Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032. 100

FIG NO. 34……… OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032. 101

FIG NO. 35……… Europe OSD Contract Manufacturing Market for Cardiovascular, Revenue (USD Million) 2018 – 2032. 102

FIG NO. 36……… Europe OSD Contract Manufacturing Market for CNS, Revenue (USD Million) 2018 – 2032. 103

FIG NO. 37……… Europe OSD Contract Manufacturing Market for Gastrointestinal, Revenue (USD Million) 2018 – 2032. 104

FIG NO. 38……… Europe OSD Contract Manufacturing Market for Oncology, Revenue (USD Million) 2018 – 2032. 105

FIG NO. 39……… Europe OSD Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032. 106

FIG NO. 40……… Europe OSD Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 107

FIG NO. 41……… Research Methodology – Detailed View.. 193

FIG NO. 42……… Research Methodology. 194

 

 

List of Tables

TABLE NO. 1. :…. Europe OSD Contract Manufacturing Market: Snapshot 28

TABLE NO. 2. :…. Drivers for the OSD Contract Manufacturing Market: Impact Analysis. 32

TABLE NO. 3. :…. Restraints for the OSD Contract Manufacturing Market: Impact Analysis. 34

TABLE NO. 4. :…. Europe OSD Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 93

TABLE NO. 5. :…. Europe OSD Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 94

TABLE NO. 6. :…. Europe OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 95

TABLE NO. 7. :…. Europe OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 95

TABLE NO. 8. :…. Europe OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 96

TABLE NO. 9. :…. Europe OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 96

TABLE NO. 10. :.. Europe OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 97

TABLE NO. 11. :.. Europe OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 97

TABLE NO. 12. :.. Europe OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 98

TABLE NO. 13. :.. Europe OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 98

TABLE NO. 14. :.. Germany OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 99

TABLE NO. 15. :.. Germany OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 99

TABLE NO. 16. :.. Germany OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 100

TABLE NO. 17. :.. Germany OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 100

TABLE NO. 18. :.. Germany OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 101

TABLE NO. 19. :.. Germany OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 101

TABLE NO. 20. :.. Germany OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 102

TABLE NO. 21. :.. Germany OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 102

TABLE NO. 22. :.. UK OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 103

TABLE NO. 23. :.. UK OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 103

TABLE NO. 24. :.. UK OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 104

TABLE NO. 25. :.. UK OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 104

TABLE NO. 26. :.. UK OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 105

TABLE NO. 27. :.. UK OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 105

TABLE NO. 28. :.. UK OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 106

TABLE NO. 29. :.. UK OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 106

TABLE NO. 30. :.. France OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 107

TABLE NO. 31. :.. France OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 107

TABLE NO. 32. :.. France OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 108

TABLE NO. 33. :.. France OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 108

TABLE NO. 34. :.. France OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 109

TABLE NO. 35. :.. France OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 109

TABLE NO. 36. :.. France OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 110

TABLE NO. 37. :.. France OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 110

TABLE NO. 38. :.. Italy OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 111

TABLE NO. 39. :.. Italy OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 111

TABLE NO. 40. :.. Italy OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 112

TABLE NO. 41. :.. Italy OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 112

TABLE NO. 42. :.. Italy OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 113

TABLE NO. 43. :.. Italy OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 113

TABLE NO. 44. :.. Italy OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 114

TABLE NO. 45. :.. Italy OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 114

TABLE NO. 46. :.. Spain OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 115

TABLE NO. 47. :.. Spain OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 115

TABLE NO. 48. :.. Spain OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 116

TABLE NO. 49. :.. Spain OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 116

TABLE NO. 50. :.. Spain OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 117

TABLE NO. 51. :.. Spain OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 117

TABLE NO. 52. :.. Spain OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 118

TABLE NO. 53. :.. Spain OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 118

TABLE NO. 54. :.. Russia OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 119

TABLE NO. 55. :.. Russia OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 119

TABLE NO. 56. :.. Russia OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 120

TABLE NO. 57. :.. Russia OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 120

TABLE NO. 58. :.. Russia OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 121

TABLE NO. 59. :.. Russia OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 121

TABLE NO. 60. :.. Russia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 122

TABLE NO. 61. :.. Russia OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 122

TABLE NO. 62. :.. BENELUX OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 123

TABLE NO. 63. :.. BENELUX OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 123

TABLE NO. 64. :.. BENELUX OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 124

TABLE NO. 65. :.. BENELUX OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 124

TABLE NO. 66. :.. BENELUX OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 125

TABLE NO. 67. :.. BENELUX OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 125

TABLE NO. 68. :.. BENELUX OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 126

TABLE NO. 69. :.. BENELUX OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 126

TABLE NO. 70. :.. Austria OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 127

TABLE NO. 71. :.. Austria OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 127

TABLE NO. 72. :.. Austria OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 128

TABLE NO. 73. :.. Austria OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 128

TABLE NO. 74. :.. Austria OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 129

TABLE NO. 75. :.. Austria OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 129

TABLE NO. 76. :.. Austria OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 130

TABLE NO. 77. :.. Austria OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 130

TABLE NO. 78. :.. Denmark OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 131

TABLE NO. 79. :.. Denmark OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 131

TABLE NO. 80. :.. Denmark OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 132

TABLE NO. 81. :.. Denmark OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 132

TABLE NO. 82. :.. Denmark OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 133

TABLE NO. 83. :.. Denmark OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 133

TABLE NO. 84. :.. Denmark OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 134

TABLE NO. 85. :.. Denmark OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 134

TABLE NO. 86. :.. Sweden OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 135

TABLE NO. 87. :.. Sweden OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 135

TABLE NO. 88. :.. Sweden OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 136

TABLE NO. 89. :.. Sweden OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 136

TABLE NO. 90. :.. Sweden OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 137

TABLE NO. 91. :.. Sweden OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 137

TABLE NO. 92. :.. Sweden OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 138

TABLE NO. 93. :.. Sweden OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 138

TABLE NO. 94. :.. Switzerland OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 139

TABLE NO. 95. :.. Switzerland OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 139

TABLE NO. 96. :.. Switzerland OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 140

TABLE NO. 97. :.. Switzerland OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 140

TABLE NO. 98. :.. Switzerland OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 141

TABLE NO. 99. :.. Switzerland OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 141

TABLE NO. 100. :. Switzerland OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 142

TABLE NO. 101. :. Switzerland OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 142

TABLE NO. 102. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 143

TABLE NO. 103. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 143

TABLE NO. 104. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By Mechanism, 2018 – 2023 (USD Million) 144

TABLE NO. 105. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By Mechanism, 2024 – 2032 (USD Million) 144

TABLE NO. 106. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By End-user, 2018 – 2023 (USD Million) 145

TABLE NO. 107. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By End-user, 2024 – 2032 (USD Million) 145

TABLE NO. 108. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 146

TABLE NO. 109. :. Rest of Europe OSD Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 146

What is the current value and growth projection of the European oral solid dosage contract manufacturing market?

The European market for oral solid dosage contract manufacturing was valued at USD 6,280.24 million in 2023. It is projected to grow at a compound annual growth rate (CAGR) of approximately 5.5% from 2023 to 2032, reaching a valuation of USD 10,441.43 million by 2032.

What factors are driving the growth of the oral solid dosage contract manufacturing market in Europe?

The growth is primarily driven by the increasing demand for oral solid dosage pharmaceuticals, such as tablets and capsules. Key drivers include the complexity of emerging drug compounds, advancements in drug delivery technologies, the need for enhanced bioavailability, patient compliance, and a rising demand for generic medications. The stringent regulatory environment in Europe also plays a significant role.

Who are the key players in the European oral solid dosage contract manufacturing market?

Major participants in the market include Catalent Inc., Lonza Group, Piramal Pharma Solutions, Aenova, Jubilant, Boehringer Ingelheim, AbbVie Contract Manufacturing, Patheon, Recipharm, Next Pharma AB, Siegfried AG, and Corden Pharma. These companies are making significant investments in the development of oral solid dosage forms.

How are demographic and industry trends influencing the European oral solid dosage contract manufacturing market?

Europe’s aging population and the increase in chronic diseases are spurring higher demand for medications, including oral solid dosages. The pharmaceutical industry’s shift towards cost-effectiveness and production efficiency is leading to increased outsourcing to contract manufacturers. Additionally, there’s a growing focus on specialized therapeutic areas like oncology and neurology, and strategic collaborations between pharmaceutical companies and CMOs are also contributing to market growth.

Qatar Dental Care Market

Published:
Report ID: 30608

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Purchase Options

$1999
Delivery Format: Excel.
$2999
Designed for the individual purchaser.
$3999
Users located at a single corporate site or regional office.
$4999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN